Cargando…

Ultra-Hypofractionation for Whole-Breast Irradiation in Early Breast Cancer: Interim Analysis of a Prospective Study

We report on the early clinical outcomes of a prospective series of early breast cancer (EBC) patients treated with ultra-hypofractionated post-operative whole-breast irradiation (WBI) after breast-conserving surgery (BCS) and axillary management. Primary endpoints were patient’s compliance and acut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sigaudi, Valeria, Zannetti, Micol, Ferrara, Eleonora, Manfredda, Irene, Mones, Eleonora, Loi, Gianfranco, Krengli, Marco, Franco, Pierfrancesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599048/ https://www.ncbi.nlm.nih.gov/pubmed/36289830 http://dx.doi.org/10.3390/biomedicines10102568

Ejemplares similares

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review
por: Brignoli, Andrea, et al.
Publicado: (2023)

Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery
por: Kim, Kyung Su, et al.
Publicado: (2016)

Reproducibility of patient setup by surface image registration system in conformal radiotherapy of prostate cancer
por: Krengli, Marco, et al.
Publicado: (2009)

Hypofractionation: The standard for external beam breast irradiation
por: Brunt, Adrian Murray, et al.
Publicado: (2023)

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
por: Montero, Angel, et al.
Publicado: (2023)

Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity—A Narrative Review
por: Mireştean, Camil Ciprian, et al.
Publicado: (2022)

Radiotherapy in COVID-19 patient affected by multiple myeloma: a case report
por: Krengli, Marco, et al.
Publicado: (2020)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis, Theodora A, et al.
Publicado: (2015)

Multi-institutional phase II study of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for breast cancer in Japan: Kyoto Radiation Oncology Study Group (UPBEAT study)
por: Mitsuyoshi, Takamasa, et al.
Publicado: (2022)

Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study
por: Pinnarò, Paola, et al.
Publicado: (2017)

Hypofractionated radiotherapy in postmastectomy locally advanced breast cancer: an interim report on acute toxicities and dosimetry
por: Jamora, Kurl, et al.
Publicado: (2022)

Hypofractionated whole breast irradiation with simultaneous integrated boost in breast cancer using helical tomotherapy with or without regional nodal irradiation: A report of acute toxicities
por: Chitapanarux, Imjai, et al.
Publicado: (2023)

A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery
por: Yu, Ting, et al.
Publicado: (2021)

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity
por: Deantonio, Letizia, et al.
Publicado: (2010)

Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic
por: Ivanov, Olivera, et al.
Publicado: (2022)

Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2022)

Dosimetric effect of respiratory motion on planned dose in whole-breast volumetric modulated arc therapy using moderate and ultra-hypofractionation
por: Mankinen, Mikko, et al.
Publicado: (2022)

Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
por: Fastner, Gerd, et al.
Publicado: (2022)

Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases
por: Doré, Mélanie, et al.
Publicado: (2015)

Single-Institution Prospective Evaluation of Moderately Hypofractionated Whole-Breast Radiation Therapy With Simultaneous Integrated Boost With or Without Lymphatic Drainage Irradiation After Breast-Conserving Surgery
por: Unterkirhere, Olga, et al.
Publicado: (2023)

Magnetic field dose effects on different radiation beam geometries for hypofractionated partial breast irradiation
por: Kim, Anthony, et al.
Publicado: (2017)

Hydrofilm Polyurethane Films Reduce Radiation Dermatitis Severity in Hypofractionated Whole-Breast Irradiation: An Objective, Intra-Patient Randomized Dual-Center Assessment †
por: Schmeel, Leonard Christopher, et al.
Publicado: (2019)

Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years
por: Pinnarò, Paola, et al.
Publicado: (2010)

Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery
por: Thorpe, Cameron S., et al.
Publicado: (2022)

Incidental Axillary Dose of Tomotherapy in Hypofractionated Whole Breast Radiotherapy for Early Breast Cancer: A Dosimetrical Analysis
por: Yeo, Seung-Gu, et al.
Publicado: (2023)

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors
por: Ciammella, Patrizia, et al.
Publicado: (2014)

1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard?
por: Levy, Antonin, et al.
Publicado: (2020)

Implementation and utilization of hypofractionation for breast cancer
por: Gilbo, Philip, et al.
Publicado: (2018)

Comparing treatment uncertainty for ultra- vs. standard-hypofractionated breast radiation therapy based on in-vivo dosimetry
por: Fiagan, Yawo A.C., et al.
Publicado: (2022)

Outcome of hypofractionated breast irradiation and intraoperative electron boost in early breast cancer: A randomized non‐inferiority clinical trial
por: Fadavi, Pedram, et al.
Publicado: (2021)

18F-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment
por: Krengli, Marco, et al.
Publicado: (2022)

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
por: Krug, David, et al.
Publicado: (2021)

Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique
por: Zerella, Maria Alessia, et al.
Publicado: (2022)

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016)

Extreme weekly hypofractionation in breast cancer in elderly
por: Blanco Parajón, Sonia, et al.
Publicado: (2020)

Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution
por: Lee, Jeong Won, et al.
Publicado: (2019)

Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial
por: Lazzari, Grazia, et al.
Publicado: (2017)

Preoperative Accelerated Hyperfractionated Whole-Breast Radiation as Treatment for Secondary Angiosarcoma of the Breast After Prior Accelerated Hypofractionated Whole-Breast Radiation Therapy: A Case Report and Review of the Literature
por: Layton, Christina, et al.
Publicado: (2022)

Advances in Hypofractionated Irradiation-Induced Immunosuppression of Tumor Microenvironment
por: Wang, Yuxia
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t9gdn8h6gel27cpl8nv90krl7o